
135.60 Delayed Data As of Feb 06 | ![]() Today’s Change | 104.29 Today|||52-Week Range 138.74 | +3.28% Year-to-Date |
The investment seeks to track the investment results of the ICE Biotechnology Index composed of U.S.-listed equities in the biotechnology sector. The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
1 month | +4.88% | 3 years | +5.89% | |
3 months | +6.81% | 5 years | +4.24% | |
1 year | +5.23% | Since inception | +6.80% |
Previous close | $136.59 |
Open day’s range | 135.26 – 137.27 |
Net asset value (NAV) | 136.53 (02/03/2023) |
Daily volume | 1,478,445 |
Average volume (3 months) | 1,805,932 |
IBB | Category | |
---|---|---|
Performance 5-yr return | +4.24% | +7.62% |
Expense Gross exp ratio | 0.44% | 1.01% |
Risk 5 year sharpe ratio | 0.22 | 0.38 |
Net assets | $9.0B | $2.0B |
Average market cap | $21.2B | $52.3B |
Average P/E | 16.3 | 23.6 |
Dividend / Share | -- | 0.22% |
FHLC Fidelity MSCI Health Care Index ETF |
VHT Vanguard Health Care Index Fund ETF Shar... |
RYH Invesco S&P 500® Equal Weight Health Ca... |
Healthcare | 99.91% |
Business service | 0.09% |
Consumer goods | 0.00% |
Consumer service | 0.00% |
Energy | 0.00% |
GILD Gilead Sciences | 7.62% |
VRTX Vertex Pharmaceuticals Inc | 7.61% |
REGN Regeneron Pharmaceuticals | 7.15% |
AMGN Amgen | 7.03% |
MRNA Moderna Inc | 5.36% |
IQV IQVIA Holdings Inc | 3.89% |
BIIB Biogen | 3.80% |
MTD Mettler-Toledo International Inc | 3.10% |
ILMN Illumina Inc | 3.09% |
ALNY Alnylam Pharmaceuticals Inc | 2.54% |